QQQ   437.31 (-0.17%)
AAPL   182.45 (-1.04%)
MSFT   409.85 (-0.44%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.23 (-0.20%)
TSLA   192.55 (-2.46%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.90 (-0.29%)
T   16.78 (+1.15%)
F   12.18 (+0.50%)
MU   85.91 (+0.00%)
CGC   3.38 (+0.30%)
GE   153.16 (+0.98%)
DIS   107.78 (+0.13%)
AMC   4.50 (+1.81%)
PFE   27.79 (+0.87%)
PYPL   59.17 (+1.41%)
XOM   103.94 (-0.78%)
QQQ   437.31 (-0.17%)
AAPL   182.45 (-1.04%)
MSFT   409.85 (-0.44%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.23 (-0.20%)
TSLA   192.55 (-2.46%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.90 (-0.29%)
T   16.78 (+1.15%)
F   12.18 (+0.50%)
MU   85.91 (+0.00%)
CGC   3.38 (+0.30%)
GE   153.16 (+0.98%)
DIS   107.78 (+0.13%)
AMC   4.50 (+1.81%)
PFE   27.79 (+0.87%)
PYPL   59.17 (+1.41%)
XOM   103.94 (-0.78%)
QQQ   437.31 (-0.17%)
AAPL   182.45 (-1.04%)
MSFT   409.85 (-0.44%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.23 (-0.20%)
TSLA   192.55 (-2.46%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.90 (-0.29%)
T   16.78 (+1.15%)
F   12.18 (+0.50%)
MU   85.91 (+0.00%)
CGC   3.38 (+0.30%)
GE   153.16 (+0.98%)
DIS   107.78 (+0.13%)
AMC   4.50 (+1.81%)
PFE   27.79 (+0.87%)
PYPL   59.17 (+1.41%)
XOM   103.94 (-0.78%)
QQQ   437.31 (-0.17%)
AAPL   182.45 (-1.04%)
MSFT   409.85 (-0.44%)
META   484.11 (-0.42%)
GOOGL   143.69 (-0.28%)
AMZN   174.23 (-0.20%)
TSLA   192.55 (-2.46%)
NVDA   798.09 (+1.62%)
NIO   5.45 (-6.84%)
AMD   176.74 (-2.82%)
BABA   75.90 (-0.29%)
T   16.78 (+1.15%)
F   12.18 (+0.50%)
MU   85.91 (+0.00%)
CGC   3.38 (+0.30%)
GE   153.16 (+0.98%)
DIS   107.78 (+0.13%)
AMC   4.50 (+1.81%)
PFE   27.79 (+0.87%)
PYPL   59.17 (+1.41%)
XOM   103.94 (-0.78%)

Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

$245.20
+1.58 (+0.65%)
(As of 02:15 PM ET)

Becton, Dickinson and Company Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

$279.17
13.85% Upside
High Forecast$305.00
Average Forecast$279.17
Low Forecast$260.00
TypeCurrent Forecast
2/23/23 to 2/23/24
1 Month Ago
1/24/23 to 1/24/24
3 Months Ago
11/25/22 to 11/25/23
1 Year Ago
2/23/22 to 2/23/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$279.17$278.83$283.86$275.70
Predicted Upside13.85% Upside11.53% Upside11.40% Upside12.82% Upside
Get Becton, Dickinson and Company Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.


BDX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Becton, Dickinson and Company Stock vs. The Competition

TypeBecton, Dickinson and CompanyMedical CompaniesS&P 500
Consensus Rating Score
2.83
2.68
2.48
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside13.85% Upside2,459.90% Upside7.36% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/5/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$301.00 ➝ $305.00+28.59%
1/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$269.00 ➝ $275.00+13.95%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$310.00 ➝ $280.00+17.52%
11/10/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$305.00 ➝ $280.00+19.33%
10/2/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$282.00 ➝ $260.00+0.88%
4/4/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$280.00 ➝ $275.00+10.30%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:34 PM ET.












BDX Price Target - Frequently Asked Questions

What is Becton, Dickinson and Company's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Becton, Dickinson and Company stock is Moderate Buy based on the current 1 hold rating and 5 buy ratings for BDX. The average twelve-month price prediction for Becton, Dickinson and Company is $279.17 with a high price target of $305.00 and a low price target of $260.00. Learn more on BDX's analyst rating history.

Do Wall Street analysts like Becton, Dickinson and Company more than its competitors?

Analysts like Becton, Dickinson and Company more than other Medical companies. The consensus rating score for Becton, Dickinson and Company is 2.83 while the average consensus rating score for medical companies is 2.68. Learn more on how BDX compares to other companies.

Does Becton, Dickinson and Company's stock price have much upside?

According to analysts, Becton, Dickinson and Company's stock has a predicted upside of 14.22% based on their 12-month stock forecasts.

What analysts cover Becton, Dickinson and Company?

Becton, Dickinson and Company has been rated by Barclays, Morgan Stanley, and Raymond James in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:BDX) was last updated on 2/23/2024 by MarketBeat.com Staff